February 04, 2022
AI ‘Fingerprinting’ Fights Back Against Hard-to-Detect Cancers
Read More
Invest In Medical Technology
Change the landscape of cancer care
Why invest in Medtech & Reveal
As pressure builds on global health ecosystems to face the growing demands of an aging population and more sophisticated health care consumers, AI combined with medical technology will prove vital for years to come as a source for improving the value and effectiveness of interventional care.
According to the latest study on “Artificial Intelligence in Healthcare Diagnosis Market Forecast to 2027,” the market was valued at US$ 3,639.02 million in 2019 and is projected to reach US$ 66,811.97 million by 2027; it is expected to grow at a CAGR of 44.0% during 2020–2027.
Goals
With a focus on cancer and the capacity to deliver on other indications, we have ambitious goals. Over the next 10 years, our goal is to make Reveal Surgical’s tissue characterization platform standard of care for all cancer patients. In order to achieve this goal, we have built a team that lets us reach for the sky with our feet on the ground.
Corporate responsibility
AI4Good
Reveal Surgical is a proud partner organization with AI4Good, providing mentorships for women in the AI ecosystem. AI4Good is working towards a more inclusive tech culture, by empowering women in AI. The AI4Good Lab is a 7-week summer training program that brings together a cohort of 30 women from across Canada, offering mentorship, training, and career opportunities in the Canadian and International AI ecosystems.
To Learn more about AI4Good click here
Corporate culture
Reveal Surgical is first and foremost a culture of service. We spend our time, energy, and talents helping others. We build things to help surgeons and oncologists do a better job. We are here to help improve the lives of patients through better procedure outcomes and improved safety. We are here to help our partner organizations live up to their missions. We are here to help each other do the best job possible. Our Values guide our decision-making on a daily basis, and our investors are an important part of that process.
Our Technology
Surgeons are often faced with critical decisions in real-time. With little margin for error, greater tumor cell identification and precise excision are key – remove too little tissue and risk fatal recurrences or remove too much and cause profound neurological damage. Learn more about how Reveal’s technology is tackling this problem.
In The Press
November 25, 2021
Detecting the previously undetectable
Read More
November 19, 2021
Made in Quebec: Illuminating hidden brain cancer cells
Read More
November 09, 2021
ODS Medical Inc has rebranded as Reveal Surgical
Read More
September 01, 2020
ODS Medical, Inc. closes a new financing round to further support product development diversification of applications
Read More
August 01, 2019
ODS Medical Inc. announces Sentry™ System prototype for real-time Raman spectroscopy receives Health Canada testing authorization
Read More
May 27, 2019
Innovation, Science and Economic Development Canada announces $49 Million investment in DHDP
Read More
October 25, 2018
ODS Medical joins forces with two American Giants
Read More
July 01, 2018
ODS Medical is a 2018 Medtech Innovator Showcase Company
Read More
January 12, 2018
Frédéric Leblond in the running for discovery of the year
Read More
Become a Research Partner
With your help, we can continue to discover new methods of tissue identification, forever changing innumerable lives.
Let’s talk
